Norges Bank
FATE icon

Norges Bank’s Fate Therapeutics FATE Stock Holding History

Norges Bank’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-42,672
Closed -$160K – 1913
2023
Q4 		$160K Hold
42,672
– – ﹤0.01% 1930
2023
Q3 		$90.5K Sell
42,672
-245,000
-85% -$812K ﹤0.01% 1960
2023
Q2 		$1.37M Sell
287,672
-666,867
-70% -$3.68M ﹤0.01% 1904
2023
Q1 		$5.44M Buy
954,539
+149,797
+19% +$904K ﹤0.01% 1731
2022
Q4 		$8.12M Buy
804,742
+99,728
+14% +$1.87M ﹤0.01% 1631
2022
Q3 		$15.8M Hold
705,014
– – ﹤0.01% 1332
2022
Q2 		$17.5M Buy
705,014
+146,386
+26% +$4.04M ﹤0.01% 1301
2022
Q1 		$21.7M Sell
558,628
-230,826
-29% -$8.94M ﹤0.01% 1362
2021
Q4 		$46.2M Buy
789,454
+25,625
+3% +$1.45M 0.01% 981
2021
Q3 		$45.3M Buy
763,829
+36,272
+5% +$2.85M 0.01% 975
2021
Q2 		$63.1M Sell
727,557
-92,848
-11% -$7.48M 0.01% 835
2021
Q1 		$67.6M Sell
820,405
-20,308
-2% -$1.95M 0.02% 802
2020
Q4 		$76.4M Sell
840,713
-33,201
-4% -$2.06M 0.02% 722
2020
Q3 		$34.9M Buy
873,914
+790,014
+942% +$27.6M 0.01% 1062
2020
Q2 		$2.88M Buy
+83,900
New +$2.5M ﹤0.01% 1930

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank's FATE Position: Q1 2024 in Review

Norges Bank sold out of Fate Therapeutics (FATE) in Q1 2024, closing a stake of 42,672 shares — an estimated $160K sold.

Norges Bank first reported a position in FATE in Q2 2020 and held it in 15 quarters. The position peaked at $76.4M in Q4 2020. 167 funds tracked by Wall St. Rank hold FATE as of Q1 2024.

  • Norges Bank reported no remaining Fate Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Norges Bank sold 42,672 Fate Therapeutics shares in Q1 2024, an estimated $160K.
  • Norges Bank first reported a position in Fate Therapeutics in Q2 2020 and held it in 15 quarters.
  • Norges Bank's Fate Therapeutics position peaked at $76.4M in Q4 2020.
  • 167 funds tracked by Wall St. Rank held Fate Therapeutics as of Q1 2024.

Based on Norges Bank's 13F filing for Q1 2024, filed 14 May 2024.